Radioprotection Dosimetry in the European Trial on BNCT Studied by an Anthropomorphic Phantom
Different parts of the patient body are exposed indirectly during BNCT treatment of glioblastoma multiforme, depending on the geometrical alignment of the patient to the beam. Successful clinical application requires applicable solutions for the shielding of the organs at risk. At present during the irradiation, there is no way to measure the dose components in vivo in other parts of the body apart from the surface.
KeywordsIonisation Chamber Boron Neutron Capture Therapy Dose Profile Anthropomorphic Phantom Cross Profile
Unable to display preview. Download preview PDF.
- 4.ICRU report 45, Clinical neutron dosimetry part I, International Commission on Radiation Units and Measurements, Bethesda MD, 1989.Google Scholar
- 5.C.P.J. Raijmaakers, “Dosimetry and Treatment Planning for Boron Neutron Capture Therapy”, Thesis, Amsterdam.Google Scholar
- 7.C. Vroegindeweij et al., Validation of the description of the epithermal neutron beam for boron Neutron capture at the HFR Petten, in “Frontiers in Neutron Capture Therapy,” M.F. Hawthorne, K. Shelly, R.W. Wiersema, eds., Kluwer Academic/Plenum Publishers, New York, 2001, pp. 375–380.CrossRefGoogle Scholar